glp-1 mimetics GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists Non-insulin injectable antidiabetic drugs -

Studies in rodents have demonstrated that GLP-1R agonists reduce hippocampal cell death by reducing the development of amyloid- plaques (McIntyre et al., 2013)

Improvements in the gut, like decreased bloating and more effortless bowel movement, are apparent after a few days, while the weight loss advantage and increase in energy levels come somewhat later

However, responses vary widely among patients, potentially due to differences in the intestinal ecosystem

[DOI] [PMC free article] [PubMed] [Google Scholar] [30].Graham DL, Madkour HS, Noble BL, et al

Yet, the Latin American GLP-1 RA market is expected to grow by a third in the next five years 15

Trust me, I speak from personal experience